|
Apr 29
|
How expanded use of GLP-1s could affect long-term outlooks for Eli Lilly and Novo Nordisk
|
|
Apr 29
|
UPDATE 2-One dose of Novo Nordisk's Wegovy back in supply, FDA website shows
|
|
Apr 29
|
How To Earn $500 A Month From Eli Lilly Stock Ahead Of Q1 Earnings Report
|
|
Apr 29
|
Here's How Much Stock Eli Lilly Repurchased in 2023
|
|
Apr 29
|
Novo Nordisk: Growth Is Still A Better Choice
|
|
Apr 29
|
Pipeline Moves: Investigator-led trial of Lilly’s merestinib in solid tumours terminated
|
|
Apr 28
|
Eli Lilly Just Announced More Good News: Time to Buy?
|
|
Apr 27
|
Forget Nvidia, These Unstoppable Stocks Are Better Buys
|
|
Apr 27
|
1 Unstoppable Pharmaceutical Stock Investors Shouldn't Sleep On
|
|
Apr 27
|
Goldman Sachs’ Top 15 Stock Picks for 2024
|
|
Apr 27
|
3 Dividend Stocks to Buy and Hold for the Next Decade
|
|
Apr 26
|
Dow Jones Futures: Nvidia Leads 7 New Buys As Market Roars; Fed, Apple, Super Micro Loom
|
|
Apr 26
|
How 'Megatrends' Like Weight-Loss Drugs And Smartwatches Are Bolstering ResMed
|
|
Apr 26
|
Top 20 biopharma kick off 9.6% market cap surge in Q1 2024 amid Medicare price talks
|
|
Apr 25
|
20 Fastest Growing Health Tech Companies in the World
|
|
Apr 25
|
Gear Up for Lilly (LLY) Q1 Earnings: Wall Street Estimates for Key Metrics
|
|
Apr 25
|
Zacks Industry Outlook Highlights Eli Lilly, Novo Nordisk, Merck and AbbVie
|
|
Apr 24
|
Will Healthcare ETFs Lose Momentum as Q1 Earnings Unfold?
|
|
Apr 24
|
4 Large Drug Stocks to Hold on to Amid Industry Challenges
|
|
Apr 24
|
Analysts Estimate Pfizer (PFE) to Report a Decline in Earnings: What to Look Out for
|